PCM
PTLA
Peregrine Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-514,362
| Closed | -$12.3M | – | 333 |
|
|
2019
Q4 | $12.3M | Buy |
514,362
+37,499
| +8% | +$895K | 0.31% | 129 |
|
|
2019
Q3 | $12.8M | Buy |
476,863
+12,398
| +3% | +$333K | 0.35% | 125 |
|
|
2019
Q2 | $12.6M | Buy |
464,465
+37,157
| +9% | +$1.01M | 0.31% | 135 |
|
|
2019
Q1 | $14.8M | Sell |
427,308
-117,055
| -22% | -$4.06M | 0.37% | 124 |
|
|
2018
Q4 | $10.6M | Buy |
+544,363
| New | +$10.6M | 0.3% | 141 |
|
|
2017
Q1 | – | Sell |
-459,367
| Closed | -$10.3M | – | 266 |
|
|
2016
Q4 | $10.3M | Buy |
459,367
+7,799
| +2% | +$175K | 0.27% | 165 |
|
|
2016
Q3 | $10.3M | Buy |
+451,568
| New | +$10.3M | 0.27% | 161 |
|